Johnson & Johnson acquires Centocor.
Hodgson
J
J
D000077284:Abciximab; D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D001709:Biotechnology / Q000191:economics*; D003132:Commerce / Q000191:economics; D004345:Drug Industry / Q000191:economics*; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors
D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab